Equity Details
Price & Market Data
Price: $0.0642
Daily Change: -$0.00135 / 2.10%
Daily Range: $0.0623 - $0.067
Market Cap: $31,953,970
Daily Volume: 350,705
Performance Metrics
1 Week: -7.00%
1 Month: -21.51%
3 Months: -16.69%
6 Months: -28.90%
1 Year: -54.08%
YTD: -5.87%
About Vivos Inc. (RDGL)
A complete market overview for Vivos Inc. (RDGL). The stock is at 0.0642, with a daily change of -$0.00135 / 2.10%. Market cap: 31,953,970. Delve into its YTD and 3-month performance.
Company Details
Employees: 1
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. The company develops an yttrium-90 based precision radionuclide therapy device; RadioGel, which is an injectable particle-gel for Precision Radionuclide Therapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. It is also developing a universal laboratory cooling device; hydrogel; and other products under the Alpha-Gel, Beta-Gel, Gamma-Gel, and Precisiongel names. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Kennewick, Washington.